Cost-effectiveness of obinutuzumab for chronic lymphocytic leukaemia in The Netherlands

Hedwig Blommestein; Saskia de Groot; MJ Aarts; P (Pepijn) Vemer; R de Vries; AFM Abeelen; EFM Posthuma; Carin Uyl - de Groot

doi:10.1016/j.leukres.2016.09.005

Cost-effectiveness of obinutuzumab for chronic lymphocytic leukaemia in The Netherlands

Hedwig Blommestein, Saskia de Groot, MJ Aarts, P (Pepijn) Vemer, R de Vries, AFM Abeelen, EFM Posthuma, Carin Uyl - de Groot

Health Technology Assessment (HTA)

Research output: Contribution to journal › Article › Academic › peer-review

12 Citations (Scopus)

11 Downloads (Pure)

Original language	English
Pages (from-to)	37-45
Number of pages	9
Journal	Leukemia Research
Volume	50
DOIs	https://doi.org/10.1016/j.leukres.2016.09.005
Publication status	Published - 2016

Access to Document

10.1016/j.leukres.2016.09.005

REPUB_96834_OA.pdfFinal published version, 1.51 MB

http://hdl.handle.net/1765/96834

Cite this

@article{cffa5f13cab34d10af7a762e734e9bb2,

title = "Cost-effectiveness of obinutuzumab for chronic lymphocytic leukaemia in The Netherlands",

author = "Hedwig Blommestein and {de Groot}, Saskia and MJ Aarts and Vemer, {P (Pepijn)} and {de Vries}, R and AFM Abeelen and EFM Posthuma and {Uyl - de Groot}, Carin",

year = "2016",

doi = "10.1016/j.leukres.2016.09.005",

language = "English",

volume = "50",

pages = "37--45",

journal = "Leukemia Research",

issn = "0145-2126",

publisher = "Elsevier Ltd.",

}

TY - JOUR

T1 - Cost-effectiveness of obinutuzumab for chronic lymphocytic leukaemia in The Netherlands

AU - Blommestein, Hedwig

AU - de Groot, Saskia

AU - Aarts, MJ

AU - Vemer, P (Pepijn)

AU - de Vries, R

AU - Abeelen, AFM

AU - Posthuma, EFM

AU - Uyl - de Groot, Carin

PY - 2016

Y1 - 2016

U2 - 10.1016/j.leukres.2016.09.005

DO - 10.1016/j.leukres.2016.09.005

M3 - Article

SN - 0145-2126

VL - 50

SP - 37

EP - 45

JO - Leukemia Research

JF - Leukemia Research

ER -